from Breakingviews:

IPO exuberance ensnares Deutsche, Wells Fargo

August 14, 2014

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Inversions start to spin out of control

July 30, 2014

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own. 

from Breakingviews:

Allergan bosses put money where their mouths are

July 24, 2014

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Tax-arbitrage M&A requires a deep discount

July 2, 2014

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.  

from Breakingviews:

M&A shows symptoms of overheating

June 9, 2014

By Robert Cyran and Kevin Allison

The authors are Reuters Breakingviews columnists. The opinions expressed are their own.

from Breakingviews:

Valeant urges $54 bln deal with carrot, two sticks

June 2, 2014

By Robert Cyran

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Glaxo wrestles with its past

May 28, 2014

By Neil Unmack

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Failed bid would leave Astra under pressure

May 27, 2014

By Chris Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Astra-Pfizer needs a fresh start later in the year

May 21, 2014

By Chris Hughes
The author is a Reuters Breakingviews columnist. The opinions expressed are his own.

from Breakingviews:

Loophole offers Pfizer risky way back into AZ deal

May 20, 2014

By Chris Hughes

The author is a Reuters Breakingviews columnist. The opinions expressed are his own.